SEC Filing Details
Apr 8, 2020
Dec 31, 2019
Amendment to a previously filed 10-K
KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.